BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Opna Bio Announces Orphan Drug Designation Granted to OPN-2853 (Zavabresib) for the Treatment of Myelofibrosis

  January 22, 2026

   · 

  2 min read
• Press Releases

  OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)

  January 22, 2026

   · 

  4 min read
• Press Releases

  TridentCare Announces Acquisition of DispatchHealth’s Imaging Business Unit

  January 22, 2026

   · 

  2 min read
• Press Releases

  KOMO Biosciences Appoints Patient Advocate Tom Whitehead and Immunotherapy Pioneer Michael Kalos, Ph.D. to Advisory Board

  January 22, 2026

   · 

  4 min read
• Press Releases

  Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

  January 22, 2026

   · 

  7 min read
• Press Releases

  NeuraLight and Teitur Trophics Announce Collaboration to Use Precision Biomarkers in TT-P34 Parkinson’s Disease Clinical Trial

  January 22, 2026

   · 

  3 min read
• Press Releases

  INTENT Biologics Receives FDA Agreement Granting a Full Waiver for its Pediatric Study Plan for PEP Biologic™ in Advanced Wound Care

  January 22, 2026

   · 

  3 min read
• Press Releases

  Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET

  January 22, 2026

   · 

  3 min read
• Press Releases

  UPDATE - BPGbio Receives FDA Orphan Drug Designation for BPM31510 for the Treatment of Primary CoQ10 Deficiency

  January 22, 2026

   · 

  3 min read
• Press Releases

  AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions

  January 22, 2026

   · 

  4 min read